Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

128.51 -3.58 (-2.71%)
Official Closing Price Updated: 7:00 PM EDT, Apr 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)
The addition to the IABP family supports uncompromised cardiac support for patients during transport 
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary Perforations 
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress
From Teleflex Incorporated
Via GlobeNewswire
TFX BREAKING NEWS: Teleflex Incorporated 20% Stock Drop Triggers Securities Fraud Investigation; Investors are Urged to Contact BFA Law if they Suffered Losses
From Bleichmar Fonti & Auld LLP
Via Business Wire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Planned Retirement of Thomas Powell As Chief Financial Officer
John Deren To Be Named Executive Vice President and Chief Financial Officer 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Intent to Separate into Two Publicly Traded Companies
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
Including market leading Arrow™ CVCs and Arterial Catheters 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
From Glancy Prongay & Murray LLP
Via Business Wire
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the Jefferies London Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
From Teleflex Incorporated
Via GlobeNewswire
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. 
From Teleflex Incorporated
Via GlobeNewswire
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
From o9
Via Business Wire
Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant
From Teleflex Incorporated
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.